Regional Analysis

Global Peptide Synthesis Market- Regional Insights

North America is expected to be the largest market for peptide synthesis during the forecast period, accounting for over 35.7% of the market share in 2023. North America has remained the dominant region in the global peptide synthesis market over the past decade. The presence of major pharmaceutical and biotechnology companies in the U.S. and Canada has fueled research and development activities in this field. These companies are actively investing in developing novel peptide-based drugs and therapeutics. Furthermore, strong government funding for healthcare and life sciences research provides impetus to peptide-based drug discovery and drives regional market growth.
The pricing of synthesized peptides in North America is among the highest globally due to the advanced technologies and production capabilities of players in this region. For instance, most American companies offering peptide synthesis services employ sophisticated techniques like solid-phase peptide synthesis, which enable the production of complex peptides. This sophisticated production comes at a premium but ensures the highest purity and yield for customers. Several North American companies also have extensive custom peptide libraries that allow academic researchers to screen millions of peptide sequences at once for their studies.
Asia Pacific market is expected to be the second-largest market for peptide synthesis, accounting for over 25.2% of the market share in 2023. Asia Pacific has emerged as the fastest-growing regional market for peptide synthesis in recent times on account of increasing investments by international manufacturers to tap into the opportunities in this region. Countries like China, India, and South Korea have emerged as global hotspots for outsourced drug discovery and manufacturing activities due to the availability of a low-cost and highly skilled scientific workforce. Domestic players in Asia Pacific are gaining expertise in custom peptide synthesis, which is attracting several multinational pharmaceutical companies to outsource their peptide needs to this region. Moreover, governments across Asia Pacific are promoting investments in biotech and biopharma sectors through initiatives like tax rebates and the easing of regulations, which is positively impacting the regional peptide synthesis market.
Europe market is expected to be the fastest-growing market for peptide synthesis, with a share of 19% during the forecast period. The growth of the market in Europe is attributed to the increasing prevalence of sexually transmitted diseases in the region.

North America: U.S. and Canada
Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
Middle East & Africa: GCC Countries, Israel, South Africa, North Africa, and Central Africa and Rest of Middle East